John M. Desmarais, Director, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 80,000 shares at $3.00 ($240K) on 2016-09-26, disclosed to the SEC on 2016-12-19.
Recurring purchase ($240k) by Director, 10% Owner following this insider's established cadence. Pattern-driven, low signal.
Nothing distinguishes this filing.